Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zibu Jianshen Wan is a proprietary traditional Chinese medicine (TCM) formulation developed and manufactured by Beijing Tong Ren Tang. Formulated as a large honey pill (大蜜丸), it is traditionally used to tonify the kidneys, regulate the spleen, eliminate dampness, and relieve abdominal distension. It is indicated for the treatment of spleen and stomach weakness, which manifests as mental fatigue, soreness and weakness in the lower back and knees, and heavy limbs. The formulation contains several herbal ingredients, including *Semen Cuscutae* (菟丝子), *Fructus Broussonetiae* (楮实子), *Semen Abutili* (苘麻子), *Semen Plantaginis* (车前子), *Cortex Cinnamomi* (肉桂), *Semen Lepidii* (葶苈子), *Fructus Jujubae* (大枣), *Exocarpium Citri Rubrum* (化橘红), and *Radix Glycyrrhizae* (甘草). In October 2026, Beijing Tong Ren Tang (Macau) received a Certificate of Registration for Zibu Jianshen Wan from the Pharmaceutical Administration Bureau of Macao, permitting its sale in the Macao Special Administrative Region.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zibu Jianshen Wan.